DOCSLIB.ORG

10 Chronic Urticaria As an Autoimmune Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
10 Chronic Urticaria As an Autoimmune Disease 10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W. Greaves Fig. 1. Chronic urticaria. Frequency of different subtypes in the authors’ practices. The proportions are probably not very different elsewhere Physical Urticarias These comprise about one third to one fourth of all urticaria patients seen in the authors’ services. The diagnosis is mainly made from careful history tak- ing, appropriate clinical examination, and physical challenge testing is per- formed when necessary. It is important to identify patients in whom a physical urticaria is the main, if not the only, cause of the patient’s symptoms. In this case, further investigation is not indicated, with rare exceptions (see below). Almost invariably, patients with this diagnosis are over-investigated by the time they are referred to the urticaria clinic. Skin prick testing, RAST (radio allergo sorbent tests), food exclusion diets, etc, are not normally indicated in patients with a physical urticaria with the exception of food-dependent exer- cise-induced urticaria, a rare variety of urticaria, which develops following exercise after food ingestion. It is also important to appreciate that different physical urticarias can oc- cur concurrently in the same patient; cold and cholinergic urticarias repre- sent a well recognised example. Furthermore, chronic ‘idiopathic’ urticaria is often associated with dermographism or delayed pressure urticaria. The in- vestigation and management of chronic urticaria should be influenced by es- tablishing the relative contributions of coexisting forms of chronic urticaria to the patient’s overall disability. Symptomatic Dermographism This common physical urticaria presents mainly in teenagers or adults of ei- ther sex. Like most physical urticarias, individual itchy wheals, produced by gentle stroking or rubbing of the skin, last less than 30 minutes before fading (Fig. 2). Angioedema and mucosal whealing do not occur and there are no Chronic Urticaria as an Autoimmune Disease 311 Fig. 2. Symptomatic Dermographism. Upper left hand panel: use of a graduated dermo- grahpometer to test for sensitivity to a dermographic stimulus. Upper right hand panel: graded wheal and flare response to a range of pressures. Lower panel: gentle stroking by round end of a pen rod with a certain pressure may readily disclose abnormal reaction of patients. systemic symptoms but pruritus is troublesome. The etiology is unknown al- though skin reactivity can be passively transferred to non-human primates by intracutaneous injection of donor serum from a dermographic patient (Murphy et al. 1987). As with the majority of physical urticarias, investigations are point- less and any role for food items has not been substantiated. The prognosis is for eventual improvement in two to three years in most patients. Low sedation antihistamines such as loratidine 10 mg, cetirizine 10 mg or fexofenadine 120–180 mg are usually effective in relieving the itch, although additional treat- ment by a sedative antihistamine such as hydroxyzine 25 mg at night may also be useful. Combinations of H1- and H2- antihistamines may be useful. Cholinergic Urticaria Cholinergic urticaria is common in children and young adults, although rare in the elderly. Historically, this type of urticaria has been classified as a phys- ical urticaria. However, a recent consensus report for “definition, classification, 312 Michihiro Hide and Malcolm W. Greaves Fig. 3. Cholinergic Urticaria. Typical monomorphic symmetrical maculopapular eruption evoked by heat or exertion or stress and routine diagnosis of urticaria” (Zuberbier et al. 2001) for urticaria and angioedema classified this urticaria as a special type of urticaria, apart from physical urticarias. Symptoms of cholinergic urticaria, typically widespread pruritic monomorphic maculopapular lesions, develop in conditions causing sweating, such as exercise, hot bath taking, or emotional stimuli (Hirschmann et al. 1987) (Fig. 3). If the patient rests, cools off or relaxes, the eruption sub- sides in 15–45 minutes. Typical areas of predilection include the face, neck, fronts of elbows, wrists and popliteal fossae, although almost any area of the body can be involved. It may be accompanied by angioedema and systemic symptoms include wheezing or, rarely, anaphylactoid symptoms. Cholinergic urticaria can be disabling, especially when provoked by occupational or emo- tional triggers. The diagnosis is established by appropriate challenge testing (Commens et al. 1978) (exercise, a hot bath or mental arithmetic) and/or skin test with acetylcholine. No further investigations are indicated. The prognosis is for gradual improvement over the course of months or years in most patients, although the authors have several patients in whom cholinergic urticaria remains unremitting. The condition normally responds reasonably well to avoidance of provoking factors, together with regular daily treatment by an H1-antihistamine, especially in children. Clinical variants include persistent cholinergic urticaria (Murphy et al. 1983), in which the rash is evident even at rest, and exercise-induced angioedema (Lawrence et al. 1981). Rarely patients may give a clear history of food provo- cation – either association of onset non-specifically with food intake, or spe- cifically with certain food items (Zuberbier et al. 1993). The pathomechanisms are incompletely understood. The local wheals can be blocked by atropinisation of the skin indicating involvement of acetylcho- line, and histamine release has also been confirmed – presumably derived from mast cells (Herxheimer 1956). Wheal and flare reaction to autologous sweat and sweat-provoked histamine release from their basophils have been Chronic Urticaria as an Autoimmune Disease 313 Fig. 4. Cold Urticaria. Local whealing response to application of an ice cube for 10 min demonstrated in some populations of patients with cholinergic urticaria (Adachi et al. 1994). These reactions have been suggested to be mediated by specific IgE, but the antigen in human sweat has not been identified yet. Cold Urticaria This less common physical urticaria occurs in children and adults. Whealing is rapidly provoked by exposure to cold fluids or cold surfaces (Fig. 4). Angi- oedema of the oropharynx is common, e.g. after sucking an iced lolly. Sys- temic symptoms are common and may be severe – especially when provoked by extensive body immersion, as in sea-bathing. Cold urticaria is due to his- tamine release (Keahey et al. 1980), and cold-reactivity can be passively transferred to non-human primates by donor serum from affected individu- als (Misch et al. 1983). The transferable factor has been variously attributed to IgE or IgM. Rarely cryoglobulins and cold agglutinin can be identified in sufferers’ serum. These are usually sought routinely but positive results are exceptional. No other investigations are worth while. In adults cold urticaria may be highly disabling especially in outdoor work- ers. It responds rather poorly to antihistamine treatment in all but the mildest cases and in children. Cold tolerance treatment (repeated cold exposure to induce a temporary refractory state) is effective but requires a highly moti- vated patient (Bentley-Phillips et al. 1976). Some remain crippled by cold sensitivity despite all these measures. 314 Michihiro Hide and Malcolm W. Greaves Delayed Pressure Urticaria This common and disabling physical urticaria is arguably not a true urticaria since the wheals characteristically are of more than 24 hours’ duration (Lawlor et al. 1989a). As its name suggests, whealing occurs following a latent period of 2–4 hours after application of pressure perpendicular to the skin. Common examples of triggering factors include a tight waistband, tight footwear and golf club, tennis racquet, or steering wheel grips. Pain is more characteristic
Load more

Recommended publications
  • Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
    Review Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation Chiara Rizzo 1, Giulia Grasso 1, Giulia Maria Destro Castaniti 1, Francesco Ciccia 2 and Giuliana Guggino 1,* 1 Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology Section, University of Palermo, Piazza delle Cliniche 2, 90110 Palermo, Italy; [email protected] (C.R.); [email protected] (G.G.); [email protected] (G.M.D.C.) 2 Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-091-6552260 Received: 30 April 2020; Accepted: 29 May 2020; Published: 3 June 2020 Abstract: Primary Sjogren Syndrome (pSS) is a complex, multifactorial rheumatic disease that mainly targets salivary and lacrimal glands, inducing epithelitis. The cause behind the autoimmunity outbreak in pSS is still elusive; however, it seems related to an aberrant reaction to exogenous triggers such as viruses, combined with individual genetic pre-disposition. For a long time, autoantibodies were considered as the hallmarks of this disease; however, more recently the complex interplay between innate and adaptive immunity as well as the consequent inflammatory process have emerged as the main mechanisms of pSS pathogenesis. The present review will focus on innate cells and on the principal mechanisms of inflammation connected. In the first part, an overview of innate cells involved in pSS pathogenesis is provided, stressing in particular the role of Innate Lymphoid Cells (ILCs). Subsequently we have highlighted the main inflammatory pathways, including intra- and extra-cellular players.
    [Show full text]
  • Vaccination and Autoimmune Disease: What Is the Evidence?
    REVIEW Review Vaccination and autoimmune disease: what is the evidence? David C Wraith, Michel Goldman, Paul-Henri Lambert As many as one in 20 people in Europe and North America have some form of autoimmune disease. These diseases arise in genetically predisposed individuals but require an environmental trigger. Of the many potential environmental factors, infections are the most likely cause. Microbial antigens can induce cross-reactive immune responses against self-antigens, whereas infections can non-specifically enhance their presentation to the immune system. The immune system uses fail-safe mechanisms to suppress infection-associated tissue damage and thus limits autoimmune responses. The association between infection and autoimmune disease has, however, stimulated a debate as to whether such diseases might also be triggered by vaccines. Indeed there are numerous claims and counter claims relating to such a risk. Here we review the mechanisms involved in the induction of autoimmunity and assess the implications for vaccination in human beings. Autoimmune diseases affect about 5% of individuals in Autoimmune disease and infection developed countries.1 Although the prevalence of most Human beings have a highly complex immune system autoimmune diseases is quite low, their individual that evolved from the fairly simple system found in incidence has greatly increased over the past few years, as invertebrates. The so-called innate invertebrate immune documented for type 1 diabetes2,3 and multiple sclerosis.4 system responds non-specifically to infection, does not Several autoimmune disorders arise in individuals in age- involve lymphocytes, and hence does not display groups that are often selected as targets for vaccination memory.
    [Show full text]
  • Autoimmunity and Organ Damage in Systemic Lupus Erythematosus
    REVIEW ARTICLE https://doi.org/10.1038/s41590-020-0677-6 Autoimmunity and organ damage in systemic lupus erythematosus George C. Tsokos ✉ Impressive progress has been made over the last several years toward understanding how almost every aspect of the immune sys- tem contributes to the expression of systemic autoimmunity. In parallel, studies have shed light on the mechanisms that contribute to organ inflammation and damage. New approaches that address the complicated interaction between genetic variants, epigen- etic processes, sex and the environment promise to enlighten the multitude of pathways that lead to what is clinically defined as systemic lupus erythematosus. It is expected that each patient owns a unique ‘interactome’, which will dictate specific treatment. t took almost 100 years to realize that lupus erythematosus, strongly to the heterogeneity of the disease. Several genes linked to which was initially thought to be a skin entity, is a systemic the immune response are regulated through long-distance chroma- Idisease that spares no organ and that an aberrant autoimmune tin interactions10,11. Studies addressing long-distance interactions response is involved in its pathogenesis. The involvement of vital between gene variants in SLE are still missing, but, with the advent organs and tissues such as the brain, blood and the kidney in most of new technologies, such studies will emerge. patients, the vast majority of whom are women of childbearing age, Better understanding of the epigenome is needed to under- impels efforts to develop diagnostic tools and effective therapeu- stand how it supplements the genetic contribution to the dis- tics. The prevalence ranges from 20 to 150 cases per 100,000 peo- ease.
    [Show full text]
  • 3628-3641-Pruritus in Selected Dermatoses
    Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2016; 20: 3628-3641 Pruritus in selected dermatoses K. OLEK-HRAB 1, M. HRAB 2, J. SZYFTER-HARRIS 1, Z. ADAMSKI 1 1Department of Dermatology, University of Medical Sciences, Poznan, Poland 2Department of Urology, University of Medical Sciences, Poznan, Poland Abstract. – Pruritus is a natural defence mech - logical self-defence mechanism similar to other anism of the body and creates the scratch reflex skin sensations, such as touch, pain, vibration, as a defensive reaction to potentially dangerous cold or heat, enabling the protection of the skin environmental factors. Together with pain, pruritus from external factors. Pruritus is a frequent is a type of superficial sensory experience. Pruri - symptom associated with dermatoses and various tus is a symptom often experienced both in 1 healthy subjects and in those who have symptoms systemic diseases . Acute pruritus often develops of a disease. In dermatology, pruritus is a frequent simultaneously with urticarial symptoms or as an symptom associated with a number of dermatoses acute undesirable reaction to drugs. The treat - and is sometimes an auxiliary factor in the diag - ment of this form of pruritus is much easier. nostic process. Apart from histamine, the most The chronic pruritus that often develops in pa - popular pruritus mediators include tryptase, en - tients with cholestasis, kidney diseases or skin dothelins, substance P, bradykinin, prostaglandins diseases (e.g. atopic dermatitis) is often more dif - and acetylcholine. The group of atopic diseases is 2,3 characterized by the presence of very persistent ficult to treat . Persistent rubbing, scratching or pruritus.
    [Show full text]
  • Pathophysiology of Immune Thrombocytopenic Purpura: a Bird's-Eye View
    Egypt J Pediatr Allergy Immunol 2014;12(2):49-61. Review article Pathophysiology of immune thrombocytopenic purpura: a bird's-eye view. Amira Abdel Moneam Adly Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt ABSTRACT and B lymphocytes (including T-helper, T- Immune thrombocytopenic purpura (ITP) is a cytotoxic, and T-regulatory lymphocytes) 6. common autoimmune disorder resulting in isolated The triggering event for ITP is unknown7, but thrombocytopenia. It is a bleeding disorder continued research is providing new insights into characterized by low platelet counts due to decreased the underlying immunopathogenic processes as well platelet production as well as increased platelet as the cellular and molecular mechanisms involved destruction by autoimmune mechanisms. ITP can in megakaryocytopoiesis and platelet turnover. present either alone (primary) or in the setting of other Although historically ITP-associated thrombo- conditions (secondary) such as infections or altered cytopenia was attributed solely to increased rates of immune states. ITP is associated with a loss of destruction of antibody- coated platelets, it has tolerance to platelet antigens and a phenotype of become evident that suboptimal platelet production accelerated platelet destruction and impaired platelet also plays a role 8. production. Although the etiology of ITP remains Bleeding is due to decreased platelet production unknown, complex dysregulation of the immune as well as accelerated platelet destruction mediated system is observed in ITP patients. Antiplatelet in part by autoantibody-based destruction antibodies mediate accelerated clearance from the mechanisms9. Most autoantibodies in ITP are circulation in large part via the reticuloendothelial isotype switched and harbor somatic mutations10, (monocytic phagocytic) system.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Urticaria - Primary Care Treatment Pathway
    DORSET MEDICINES ADVISORY GROUP Urticaria - Primary Care Treatment Pathway Urticaria – also known as hives or nettle rash – is a raised, itchy rash that can occur on just one part of the body or be spread across large areas. The weals of urticaria last less than 24 hours although patients may develop new weals on a daily basis. If urticaria clears completely within six weeks, it is known as acute urticaria. Urticaria occurring for more than six weeks is referred to as chronic urticaria. Most cases of chronic disease occur without an obvious trigger (chronic spontaneous urticaria). Some urticaria has a physical trigger such as pressure (symptomatic dermographism or delayed pressure urticaria), cold or exercise (cholinergic urticaria), or may be drug induced (e.g. by NSAIDS, ACE inhibitors and opioids). All forms of urticaria can be treated with antihistamine although physical urticaria is less likely to respond to treatment than spontaneous urticaria. Most cases of urticaria settle spontaneously within two years but the condition can last for decades in some patients. Referral criteria Refer routinely to dermatology if patients are not responding to standard treatment (see primary care treatment below, up to step 4), they can then be considered for immunomodulation treatment such as ciclosporin (can be very useful for patients thought to have an autoimmune basis for their urticaria), methotrexate or omalizumab. The diagnosis of urticaria is primarily clinical therefore do not routinely refer for allergy testing. The British Association of Dermatologists (BAD) has produced a patient information leaflet which covers this in detail for patients. PRIOR TO SPECIALIST REFERRAL -conduct a full blood count (FBC), erythrocyte sedimentation rate (ESR), thyroid function tests (TFTs), liver function tests (LFTs), and Helicobacter pylori screening (if gastrointestinal symptoms are present).
    [Show full text]
  • Results of Accepted Poster
    JSA/WAO Joint Congress 2020 Poster Session As of August 27, 2020 Abstract ID Session Number Abstract No. Seesion Abstract Title Country Efficacy and safety of levamisole as an immunodulator in the treatment of drug resistant 10004 Poster Session 1 PE1-1 Adult airway diseases India tuberculosis Clinical usefulness of serum and sputum YKL-40 in the management of asthma, ACO and 10057 Poster Session 1 PE1-2 Adult airway diseases Japan COPD Exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease 10203 Poster Session 1 PE1-3 Adult airway diseases Japan (COPD) overlap with distinct phenotypes 10289 Poster Session 1 PE1-4 Adult airway diseases Anti-allergy medication utilization in patients with Chronic Cough United States of America 10299 Poster Session 1 PE1-5 Adult airway diseases Burden of Persistent Chronic Cough in Adults in a Large Managed Care Organization United States of America Degree of skin moisture in allergic diseases varies according to complication of airway 10434 Poster Session 1 PE1-6 Adult airway diseases Japan diseases Baseline characteristics from Phase 3, randomized controlled trials (COUGH-1 and COUGH- 10538 Poster Session 1 PE1-7 Adult airway diseases United States of America 2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough Allergen avoidance clinical trial: correlation of symptom scores between 4 and 6 point 10711 Poster Session 1 PE1-8 Adult airway diseases Bulgaria scoring systems Comparison of diffusion capacity and bronchodilator responsiveness testing
    [Show full text]
  • Urticaria from Wikipedia, the Free Encyclopedia Jump To: Navigation, Search "Hives" Redirects Here
    Urticaria From Wikipedia, the free encyclopedia Jump to: navigation, search "Hives" redirects here. For other uses, see Hive. Urticaria Classification and external resourcesICD-10L50.ICD- 9708DiseasesDB13606MedlinePlus000845eMedicineemerg/628 MeSHD014581Urtic aria (or hives) is a skin condition, commonly caused by an allergic reaction, that is characterized by raised red skin wheals (welts). It is also known as nettle rash or uredo. Wheals from urticaria can appear anywhere on the body, including the face, lips, tongue, throat, and ears. The wheals may vary in size from about 5 mm (0.2 inches) in diameter to the size of a dinner plate; they typically itch severely, sting, or burn, and often have a pale border. Urticaria is generally caused by direct contact with an allergenic substance, or an immune response to food or some other allergen, but can also appear for other reasons, notably emotional stress. The rash can be triggered by quite innocent events, such as mere rubbing or exposure to cold. Contents [hide] * 1 Pathophysiology * 2 Differential diagnosis * 3 Types * 4 Related conditions * 5 Treatment and management o 5.1 Histamine antagonists o 5.2 Other o 5.3 Dietary * 6 See also * 7 References * 8 External links [edit] Pathophysiology Allergic urticaria on the shin induced by an antibiotic The skin lesions of urticarial disease are caused by an inflammatory reaction in the skin, causing leakage of capillaries in the dermis, and resulting in an edema which persists until the interstitial fluid is absorbed into the surrounding cells. Urticarial disease is thought to be caused by the release of histamine and other mediators of inflammation (cytokines) from cells in the skin.
    [Show full text]
  • Conditions Related to Inflammatory Arthritis
    Conditions Related to Inflammatory Arthritis There are many conditions related to inflammatory arthritis. Some exhibit symptoms similar to those of inflammatory arthritis, some are autoimmune disorders that result from inflammatory arthritis, and some occur in conjunction with inflammatory arthritis. Related conditions are listed for information purposes only. • Adhesive capsulitis – also known as “frozen shoulder,” the connective tissue surrounding the joint becomes stiff and inflamed causing extreme pain and greatly restricting movement. • Adult onset Still’s disease – a form of arthritis characterized by high spiking fevers and a salmon- colored rash. Still’s disease is more common in children. • Caplan’s syndrome – an inflammation and scarring of the lungs in people with rheumatoid arthritis who have exposure to coal dust, as in a mine. • Celiac disease – an autoimmune disorder of the small intestine that causes malabsorption of nutrients and can eventually cause osteopenia or osteoporosis. • Dermatomyositis – a connective tissue disease characterized by inflammation of the muscles and the skin. The condition is believed to be caused either by viral infection or an autoimmune reaction. • Diabetic finger sclerosis – a complication of diabetes, causing a hardening of the skin and connective tissue in the fingers, thus causing stiffness. • Duchenne muscular dystrophy – one of the most prevalent types of muscular dystrophy, characterized by rapid muscle degeneration. • Dupuytren’s contracture – an abnormal thickening of tissues in the palm and fingers that can cause the fingers to curl. • Eosinophilic fasciitis (Shulman’s syndrome) – a condition in which the muscle tissue underneath the skin becomes swollen and thick. People with eosinophilic fasciitis have a buildup of eosinophils—a type of white blood cell—in the affected tissue.
    [Show full text]
  • African Americans and Lupus
    African Americans QUICK GUIDE and Lupus 1 Facts about lupus n People of all races and ethnic groups can develop lupus. n Women develop lupus much more often than men: nine of every 10 It is not people with lupus are women. Children can develop lupus, too. known why n Lupus is three times more common in African American women than lupus is more in Caucasian women. common n As many as 1 in 250 African American women will develop lupus. in African Americans. n Lupus is more common, occurs at a younger age, and is more severe in African Americans. Some scientists n It is not known why lupus is more common in African Americans. Some scientists think that it is related to genes, but we know that think that it hormones and environmental factors play a role in who develops is related to lupus. There is a lot of research being done in this area, so contact the genes, but LFA for the most up-to-date research information, or to volunteer for we know that some of these important research studies. hormones and environmental What is lupus? factors play 2 n Lupus is a chronic autoimmune disease that can damage any part of a role in who the body (skin, joints and/or organs inside the body). Chronic means develops that the signs and symptoms tend to persist longer than six weeks lupus. and often for many years. With good medical care, most people with lupus can lead a full life. n With lupus, something goes wrong with your immune system, which is the part of the body that fights off viruses, bacteria, and germs (“foreign invaders,” like the flu).
    [Show full text]
  • Tests for Autoimmune Diseases Test Codes 249, 16814, 19946
    Tests for Autoimmune Diseases Test Codes 249, 16814, 19946 Frequently Asked Questions Panel components may be ordered separately. Please see the Quest Diagnostics Test Center for ordering information. 1. Q: What are autoimmune diseases? A: “Autoimmune disease” refers to a diverse group of disorders that involve almost every one of the body’s organs and systems. It encompasses diseases of the nervous, gastrointestinal, and endocrine systems, as well as skin and other connective tissues, eyes, blood, and blood vessels. In all of these autoimmune diseases, the underlying problem is “autoimmunity”—the body’s immune system becomes misdirected and attacks the very organs it was designed to protect. 2. Q: Why are autoimmune diseases challenging to diagnose? A: Diagnosis is challenging for several reasons: 1. Patients initially present with nonspecific symptoms such as fatigue, joint and muscle pain, fever, and/or weight change. 2. Symptoms often flare and remit. 3. Patients frequently have more than 1 autoimmune disease. According to a survey by the Autoimmune Diseases Association, it takes up to 4.6 years and nearly 5 doctors for a patient to receive a proper autoimmune disease diagnosis.1 3. Q: How common are autoimmune diseases? A: At least 30 million Americans suffer from 1 or more of the 80 plus autoimmune diseases. On average, autoimmune diseases strike three times more women than men. Certain ones have an even higher female:male ratio. Autoimmune diseases are one of the top 10 leading causes of death among women age 65 and under2 and represent the fourth-largest cause of disability among women in the United States.3 Women’s enhanced immune system increases resistance to infection, but also puts them at greater risk of developing autoimmune disease than men.
    [Show full text]